Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides

Journal of Laboratory and Clinical Medicine

Volumn 136, Issue 1, 2000, Pages 58-65

  Chen, Nengqian ^a,b   Liu, Yuxiu ^a,b   Greiner, Charles D ^a,b   Holtzman, Jordan L ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033806256     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.107692     Document Type: Article

References (48)

1. Phospholipid hydroperoxide glutathione peroxidase
2. Phospholipid-hydroperoxide glutathione peroxidase: Genomic DNA, cDNA and deduced amino acid sequence
3. Mitochondrial phospholipid hydroperoxide glutathione peroxidase plays a major role in preventing oxidative injury to cells
4. Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase
5. Purification and characterization of human plasma glutathione peroxidase: A selenoglycoprotein distinct from the known cellular enzymes
6. Primary structure of human plasma glutathione peroxidase deduced from cDNA sequences
7. Mouse plasma glutathione peroxidase: cDNA sequence analysis and renal proximal tubular expression and secretion
8. Probucol inhibits oxidative modification of low density lipoprotein
9. Low density lipoprotein rich in oleic acid is protected against oxidative modification: Implications for dietary prevention of atherosclerosis
10. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
11. Exogenous oxidized low-density lipoprotein injures and alters the barrier function of endothelium in rats in vivo
12. Antioxidants and atherosclerotic heart disease
13. Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations
14. Existence of 7 alpha- and 7 beta-hydroperoxycholest-5-en-3 beta-ols in lipoproteins from diabetic patients and normal subjects
15. Simultaneous determination of phospholipid hydroperoxides and cholesteryl ester hydroperoxides in human plasma by high-performance liquid chromatography with chemiluminescence detection
16. Detection of chemiluminescence in lipid peroxidation of biological systems and its application to HPLC
17. Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay
18. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors
19. Direct measurement by single photon counting of lipid hydroperoxides in human plasma and lipoproteins
20. Evidence of the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit man
21. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease
22. Autoantibodies against oxidised LDL and progression of carotid atherosclerosis
23. Plasma, platelet and erythrocyte glutathione peroxidases as risk factors in ischaemic heart disease in man
24. Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease
25. The thioredoxin and glutaredoxin systems are efficient electrons donors to human plasma glutathione peroxidase
26. Dynamic state of glutathione in blood plasma
27. Blood and plasma glutathione measured in healthy subjects by HPLC: Relation to sex, aging, biological variables, and life habits
28. Measurement of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery
29. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection
30. Radioenzymic determination of homocysteine in plasma and urine
31. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background
32. Plasma homocysteine levels and mortality in patients with coronary artery disease
33. Glutathione peroxidase isolated from plasma reduces phospholipid hydroperoxides
34. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
35. Evidence that casein kinase 2 phosphorylates hepatic, microsomal, calcium binding proteins 1 and 2 (ERp72) but not 3 (calreticulin)
36. 14C]-acetaminophen to mouse hepatic microsomal proteins: The specific binding to calreticulin and the two forms of the thiol:protein disulfide oxidoreductases
37. Endoplasmic reticulum of rat liver contains two proteins closely related to skeletal sarcoplasmic reticulum Ca-ATPase and calsequestrin
38. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure some applications
39. Purification and characterization of a new isozyme of thiol:protein disulfide oxidoreductase from rat hepatic microsomes: Relationship of this isozyme to cytosolic, phosphatidylinositol specific phospholipase C form 1A
40. Single vertical spin density gradient ultracentrifugation
41. Characterization and partial amino acid sequence of human plasma glutathione peroxidase
42. Relation of serum homocysteine lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study
43. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke
44. Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atheresclerosis: A prospective, controlled analysis
45. Oxidative stress, caloric restriction and aging
46. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease
47. Impairment of endothelial functions by acute hyperhomocysteinemia reversal by antioxidant vitamins